6533b85bfe1ef96bd12bb611

RESEARCH PRODUCT

Neoadjuvant oxaliplatin (OXA), raltitrexed (TOM), 5-fluorouracil (FU) and folinic acid (FA) + radiotherapy followed by optimal surgery in locally advanced rectal cancer (LARC)

P. MaroneA. AvalloneAlfredo BudillonPasquale ComellaAntonella PetrilloE. RavoSecondo LastoriaFabiana TatangeloPaolo DelrioIgnazio Carreca

subject

OncologyCancer Researchmedicine.medical_specialtyintegumentary systemColorectal cancerbusiness.industrymedicine.medical_treatmentLocally advancedmedicine.diseaseSurgeryOxaliplatinRadiation therapyFolinic acidmedicine.anatomical_structureOncologyFluorouracilInternal medicinemedicineSphinctersense organsbusinessRaltitrexedmedicine.drug

description

9624 Background: Preoperative chemoradiation in LARC may produce downstaging and downsizing of the tumor, increases the change of better local control and, in selected cases, sphincter sparing proc...

http://hdl.handle.net/10447/11913